Active Kinase Proteins for Inhibitor Screening and Enzyme Assay Development

Selecting active kinase proteins for inhibitor screening and enzyme assay development requires more than matching a target name. The recombinant enzyme must contain the intended catalytic region, mutation and regulatory components, and it must be compatible with the substrate, ATP concentration, metal cofactors, detection chemistry and screening format.

Beta LifeScience offers a dedicated recombinant kinase collection covering protein kinases, lipid kinases, metabolic kinases and disease-associated variants. Researchers can begin with catalog-listed active proteins or request semi-custom and full-custom evaluation when a project requires another mutation, construct, tag, activation state, quantity or activity-assay configuration.

Request Kinase Matching and a Quote

Quick Guide to Selecting an Active Recombinant Kinase

The best starting reagent is an active kinase that represents the biological target and has activity evidence relevant to the planned assay. A product-page “Active” designation is useful for initial selection, while a documented substrate, method and specific-activity value provide stronger guidance for assay transfer.

Featured Active Kinase Proteins for Screening

The following catalog products illustrate quantitative activity-documented kinases and additional catalog-listed active formats. Numerical results apply to the product-page test configuration. Where a public page lists “Active” without a method or value, request current activity documentation before selecting the reagent for inhibitor screening.

These products are individual purchasing examples rather than a matched kinase panel. Specific activity values should not be compared directly when constructs, substrates, ATP concentrations or detection methods differ. Already selected a kinase target? Share the gene, mutation, construct, assay platform, substrate, ATP conditions and required quantity for catalog-product matching or custom quotation review.

Request Active Kinase Product Matching

How to Choose Active Kinase Proteins for Inhibitor Screening

Confirm the kinase class and reaction

Protein kinases transfer phosphate from ATP to serine, threonine or tyrosine residues; lipid kinases phosphorylate lipids, while metabolic and nucleoside kinases act on small molecules. The class determines the substrate, reaction environment and detection method. For PI3K and other lipid kinases, confirm the lipid format and regulatory-subunit composition.

Select the correct construct

A soluble kinase domain provides a focused biochemical reagent, while extended or full-length constructs may retain domains affecting conformation, autoinhibition or substrate recognition. Receptor tyrosine-kinase products often represent intracellular domains rather than complete membrane receptors. Review the amino-acid range, tag and molecular format; for PI3K p110α/p85α, confirm both catalytic and regulatory components.

Align wild-type and mutant proteins

Kinase mutations can change activity, ATP affinity, inhibitor binding or conformation. Align wild-type and mutant constructs, tags, hosts and activity methods. If catalog products differ, use them as individual feasibility reagents or submit both sequences for coordinated evaluation before interpreting potency differences as mutation-specific.

Verify the activation and phosphorylation state

Some kinases require upstream phosphorylation, autophosphorylation, a partner or another activation step. Review whether the enzyme is active, phosphorylated or unactivated, how activity was established and whether activation-site evidence is available when essential.

Evaluate tag placement and formulation

GST can support solubility but adds molecular size; His tags provide a smaller affinity handle. Confirm that the listed tag placement is unlikely to interfere with the catalytic site, regulatory interface or planned immobilization strategy. For a new construct, request a tag position selected around the structural and assay requirements. Confirm that glycerol, salts, glutathione, DTT, EDTA, PMSF and other formulation components are compatible with the substrate, compound library and detection chemistry.

Choose a Kinase Assay Detection Format

ADP-detection and luminescence assays

ADP-detection assays quantify ADP generated as the kinase consumes ATP and suit plate-based screening. Include controls for compounds that interfere with coupled enzymes or luminescence.

ATP-depletion assays

ATP-depletion methods measure remaining ATP. They are scalable, but luciferase interference can create apparent activity changes. Optimize measurable ATP consumption without exhausting substrate.

Phospho-antibody assays

ELISA, TR-FRET and related formats detect a phospho-substrate or epitope. Evaluate antibody affinity, epitope accessibility and compound fluorescence.

Radiometric assays

Radiometric methods directly track phosphate transfer and provide a sensitive reference format, with appropriate safety and waste procedures. Confirm important hits by an orthogonal method.

Optimize ATP, Substrate and Enzyme Concentrations

Kinase inhibitor potency depends strongly on assay conditions. ATP-competitive inhibitors can show different IC50 values when ATP concentration changes. Substrate identity and concentration can also affect catalytic rate, assay window and apparent inhibition.

The NIH Assay Guidance Manual chapter on protein kinase enzymes recommends balanced conditions for these bisubstrate reactions. Its broader enzymatic-assay guidance advises determining initial-rate conditions, enzyme linearity and Km values; kinase-assay ATP concentration is commonly evaluated around or below the apparent Km when the objective is to detect ATP-competitive inhibitors.

Before screening a compound library:

• titrate kinase concentration to identify a linear signal window;
• determine reaction linearity over time;
• evaluate ATP and substrate saturation behavior;
• keep substrate conversion within the intended initial-rate range;
• maintain Mg²⁺ or another required divalent cation consistently;
• keep DMSO concentration matched across wells;
• include no-enzyme and no-substrate controls;
• include a known inhibitor where available; and
• run compound-only controls to detect optical or coupled-enzyme interference.

For high-throughput development, evaluate the signal-to-background ratio, coefficient of variation and Z′ factor using representative positive- and negative-control wells across multiple plates. Plate-level performance should be established under the final enzyme, ATP, substrate, DMSO and incubation conditions rather than inferred from a single enzyme titration.

Interpret IC50, Ki and Specific Activity Correctly

Specific activity describes phosphate-transfer performance under a defined substrate, ATP and assay configuration. It is not a universal property that can be compared across unrelated methods. An enzyme with a lower published specific activity may still provide an effective screen after assay optimization.

IC50 is also configuration-dependent. It can shift with ATP, substrate and enzyme concentrations, preincubation time and inhibitor mechanism. Use enough compound concentrations to define both response plateaus, confirm hits in repeat concentration–response experiments and assess whether Ki, reversibility, time dependence or tight-binding analysis is needed.

Selectivity claims require testing against relevant off-target kinases under comparable conditions. Comparing unrelated values collected from different product pages or assay platforms does not provide a controlled selectivity profile. Researchers establishing Km, Vmax and inhibition models can also review Beta LifeScience’s guide to enzyme kinetics before defining the final screening conditions.

Build a Wild-Type, Mutant or Kinase-Family Panel

A resistance panel may include wild type, disease-associated mutants and related kinases. A pathway panel can include upstream and downstream enzymes, while a selectivity panel should include relevant off-targets.

Submit the complete target list in one request so construct compatibility, available activity evidence, quantities and custom requirements can be evaluated together.

Choose a Catalog, Semi-Custom or Full-Custom Kinase Route

Sequence changes, activation strategies and project-specific kinase assays depend on target feasibility and the agreed statement of work. An established catalog product may provide the fastest feasibility route before commissioning aligned or specialized formats.

Why Source Active Kinase Proteins from Beta LifeScience?

Beta LifeScience combines a broad kinase catalog with semi-custom and full-custom production routes. Buyers can compare available wild-type, mutant, full-length, domain and multi-subunit formats, then request technical evaluation when another sequence, host, tag, formulation, quantity or activity package is required.

Depending on project feasibility and scope, options may include:

• insect, mammalian, bacterial or yeast expression evaluation;
• kinase-domain, full-length, fusion and multi-subunit construct planning;
• wild-type, mutant and ortholog production;
• tag, purification and formulation selection;
• purity, identity, endotoxin and activity testing; and
• bulk quantity or coordinated-panel review.

Product-specific documentation should guide catalog purchases. For custom work, define the substrate, ATP conditions, detection platform and activity acceptance criteria before production so the quotation separates core deliverables from optional assay development.

Information to Include in a Kinase Quote Request

Provide a quote-ready specification:

1. Kinase name, species, accession and complete sequence
2. Wild-type or exact mutation nomenclature
3. Required expression range and regulatory domains
4. Preferred host, tag and tag position
5. Required activation or phosphorylation state
6. Substrate, ATP range, cofactors and assay buffer
7. Detection platform and plate format
8. Activity, purity, endotoxin and aggregation requirements
9. Quantity, concentration, vial size and delivery schedule
10. Comparator kinases and required documentation

Include any previous expression, activity or inhibitor data. Sharing all planned constructs together supports a more informative technical review and quotation.

FAQs

What makes a recombinant kinase suitable for inhibitor screening?

It should contain the required catalytic construct or complex, represent the intended mutation and activation state, and demonstrate activity in a compatible substrate and ATP configuration.

Does “Active” mean the kinase is validated in my assay?

It indicates activity according to the supplier's documented qualification. Reconfirm performance with the final substrate, ATP concentration, buffer and detection method before screening compounds.

Should I use a full-length kinase or catalytic domain?

A catalytic domain can provide a focused biochemical reagent. Choose full length or an extended construct when regulatory domains, autoinhibition, partner binding or an allosteric site is important.

Why does ATP concentration affect inhibitor IC50?

ATP competes with ATP-site inhibitors. Increasing ATP can increase the apparent IC50 of competitive compounds, so record and align ATP conditions when comparing results.

Can I compare wild-type and mutant kinase product-page values directly?

Only when constructs and assay conditions are aligned. Otherwise, establish both proteins in the same assay or request coordinated production and testing.

Can Beta LifeScience evaluate a custom kinase panel?

Yes. Submit the target list, sequences, mutations, assay platform and activity requirements for feasibility, product matching and quotation review.

Compare Active Kinases for Your Screening Workflow

Select active kinase proteins by enzyme class, species, mutation, construct, activation state, tag, substrate and documented activity. Begin with a catalog product when its tested format fits the assay; request semi-custom or full-custom evaluation when the project needs aligned variants, specialized formats, additional QC or larger quantities.

• Compare Active Kinase Proteins
• Request Kinase Product Matching and a Quote

Alternatively, email inquiry@betalifesci.com with the target, sequence, mutation, assay format, substrate, ATP conditions, quantity and QC requirements.